3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
138
Other
1
Classical hematology
1
Conditions
Prostatic Neoplasms
1
Osteoporosis
1
Hot Flashes
1
Anemia
1
Interventions
olaparib
2
Epoetin Alfa
2
Darbepoetin alfa
2
Carboplatin
2
venetoclax
1
trametinib
1
talazoparib
1
ruxolitinib
1
regorafenib
1
ponatinib
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
neratinib
1
lorlatinib
1
lenvatinib
1
idelalisib
1
enzalutamide
1
entrectinib
1
enasidenib
1
durvalumab
1
dehydroftorafur
1
darolutamide
1
dacomitinib
1
dabrafenib
1
copanlisib
1
cobimetinib
1
cabozantinib
1
cabazitaxel
1
bicalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Goserelin
×
Classical hematology
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled